A massive recall has been issued for three million diabetes glucose monitors following reports of seven deaths and more than…
Read More
GLP-1 Drugs Transition from Niche Treatments to Mainstream Health Solution
GLP-1 receptor agonists, once considered a niche treatment primarily for type 2 diabetes, are rapidly becoming a mainstream option for…
Read More
Eli Lilly Reports Record Q3 2025 Earnings Driven by Diabetes and Obesity Drugs
Eli Lilly delivered a standout performance in the third quarter of 2025, surpassing analysts’ expectations across revenue and earnings. The…
Read More
Newly Named “Type 5” Diabetes Recognizes Malnutrition-Linked Form with Unusual Symptoms
Medical researchers have formally recognized a distinctive form of diabetes tied to malnutrition and atypical symptoms. For years, cases that…
Read More
A Silent Crisis: Nearly Half of People with Diabetes Worldwide Are Undiagnosed
September 2025 — A startling new global study reveals that 44 percent of people aged 15 and older with diabetes…
Read More
